Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (3)
  • 2024 (11)
  • 2023 (21)
  • 2022 (21)
  • 2021 (52)
  • 2020 (11)
  • 2003 (0)

Subject

  • Drug Trafficking (24)
  • Prescription Drugs (20)
  • Pharmaceuticals/Pharmacists/Physicians (19)
  • Synthetic drugs (19)
  • Seizures (Drugs/Property) (15)
  • Task Forces/Task Force Officers (15)
  • Diversion Division (12)
  • Major Law Enforcement Operation (11)
  • Arrests/Convictions - Major (9)
  • OCDETF/Task Force (8)
  • Outreach/Drug Prevention (7)
  • Overdose (7)
  • Guilty Plea (6)
  • Prevention/Education - DEA websites GSAD, JTT etc (4)
  • Dark Web- Internet Trafficking (2)
  • Guns/Weapons (2)
  • Public and Media Affairs - also see Congressional Affairs (2)
  • Take Back Day (2)
  • Fake Pills (1)
  • Intelligence Division - Intelligence Products (1)
  • Narcoterrorism (1)

Drug Name

  • Fentanyl (267)
  • Methamphetamine (256)
  • Cocaine (246)
  • Heroin (151)
  • Oxycodone (58)
  • Marijuana (Cannabis) (52)
  • Synthetic Opioids (28)
  • Benzodiazepines (9)
  • Amphetamines (8)
  • Ecstasy/MDMA (5)
  • Morphine (5)
  • Hydromorphone (4)
  • K2/Spice (3)
  • Methadone (3)
  • Ketamine (2)
  • Steroids (2)
  • LSD (1)
  • Marijuana Concentrates (1)
  • Opioids (52)

Field Division

  • Washington, DC (28)
  • Dallas (3)
  • Miami (3)
  • Sede (3)
  • Atlanta (2)
  • Chicago (2)
  • Houston (2)
  • New Jersey (2)
  • Seattle (2)
  • St. Louis (2)
  • Detroit (1)
  • New York (1)
  • San Francisco (1)
Clear All Results
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

Noviembre 30, 2021
Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...
Noviembre 30, 2021
PRESS RELEASE

Hanover Man Pleads Guilty to Distribution of Fentanyl, Cocaine, and Other Drugs Shipped Through the Mail from California to Maryland

Noviembre 22, 2021
Baltimore, Md., – Dwight Antonio Pitts, age 47, of Hanover, Maryland, pleaded guilty on November 19, 2021, to charges related to his participation in a drug distribution conspiracy involving large amounts of fentanyl, cocaine, and other drugs, shipped through the U.S. Mail from California to Maryland. The guilty plea was...
Noviembre 22, 2021
PRESS RELEASE

Post Falls Doctor Pays $110,000 for Overprescribing Opioids

Noviembre 22, 2021
COEUR D’ALENE – Dr. Eric Benson, an internist practicing medicine in Post Falls, Idaho, agreed to pay $110,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients between 2014-2021. The settlement, which was based in part on Dr. Benson’s ability to pay, also restricts the...
Noviembre 22, 2021
PRESS RELEASE

Federal Consent Decree Permanently Bans Baltimore-Based Physician Assistant from Prescribing Opioids and Controlled Substances

Noviembre 19, 2021
Baltimore, Md., – U.S. District Judge Deborah L. Boardman has approved a consent decree that permanently enjoins Elizabeth J. Allen, a Baltimore-based physician assistant, from prescribing opioids and other controlled substances, resolving the United States’ civil allegations that Allen violated the Controlled Substances Act (CSA) in illegally prescribing opioids. Under...
Noviembre 19, 2021
PRESS RELEASE

Doctor Convicted of Illegally Prescribing Opioids to Patients

Noviembre 19, 2021
SACRAMENTO, Calif. — Physician Edmund Kemprud, 78, of Dublin, was convicted today of 14 counts of illegally prescribing opioids and other controlled substances patients, Acting U.S. Attorney Phillip A. Talbert announced. According to evidence presented at trial, Kemprud was a physician licensed to practice medicine in California and worked in...
Noviembre 19, 2021
PRESS RELEASE

Drug Dealer Pleads Guilty to Heroin Distribution and Admits That Heroin He Distributed Resulted in a Fatal Overdose

Noviembre 18, 2021
Greenbelt, Md., – Edwin Kerry Smith, age 43, of Silver Spring, Maryland, pleaded guilty today to possession with intent to distribute a controlled substance and admitted that heroin he distributed to one victim resulted in the victim’s fatal overdose. The guilty plea was announced by Jarod Forget, Special Agent in...
Noviembre 18, 2021
PRESS RELEASE

Administrator Anne Milgram Remarks on the Overdose Epidemic

Noviembre 17, 2021
Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...
Noviembre 17, 2021
PRESS RELEASE

Pharmacist Found Guilty of Illegally Dispensing and Distributing Controlled Substances

Noviembre 10, 2021
ATLANTA - Thomas Ukoshovbera A. Gbenedio has been convicted by a federal jury of illegally dispensing and distributing controlled substances from his pharmacy. “Removing and ultimately eliminating healthcare providers who unlawfully dispense pharmaceutical products for non-medical reasons is an important part of DEA’s mission,” said Special Agent in Charge of...
Noviembre 10, 2021
PRESS RELEASE

DEA’s National Prescription Drug Take Back Day Brings in 745,000 Pounds of Unneeded Medications, Continues Fight Against Opioid Epidemic

Noviembre 01, 2021
Washington, D.C., – The DEA, along with its law enforcement partners, removed close to 745,000 pounds of unneeded prescriptions from medicine cabinets across the country this past Saturday, October 23rd, as part of DEA’s ongoing commitment to turn the tide against the U.S. opioid epidemic. Following last month’s 21st National...
Noviembre 01, 2021
PRESS RELEASE

Federal Court Orders Tampa Pharmacy to Close in Case Alleging Unlawful Opioid Distribution

Noviembre 01, 2021
MIAMI - A federal court in Florida ordered a Tampa-area pharmacy shut down and prohibited two of its employees from ever owning, managing or operating any business where controlled substances are dispensed. Pursuant to an agreed consent judgment and permanent injunction filed in U.S. District Court for the Middle District...
Noviembre 01, 2021
Showing 1 - 10 of 52 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Siguiente página ›
  • Última página »

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español